IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Beta Drugs IPO listing price is ₹ 101.95, issue price is [●], and currently trading at ₹ 1884.45 as on May 30, 2025. Beta Drugs IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Beta Drugs IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Baddi and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Beta Drugs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Beta Drugs IPO offer price is ₹ 85.00 and got listed at ₹ 101.95. Read Beta Drugs IPO details mentioned above.The IPO of Beta Drugs Limited was listed on 12th October 2017. As of today, Beta Drugs IPO is trading at ₹ 1884.45, compared to the previous day’s close of ₹ 1876.50. Read the report above for detailed IPO performance.
The issue price of Beta Drugs IPO was [●] per equity share.
Beta Drugs IPO was listed at ₹101.95 on the stock exchange on 12th October 2017. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Beta Drugs IPO is ₹ 1884.45.
The 52-week high for Beta Drugs IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Beta Drugs IPO listed at ₹ 101.95 against the issue price of [●] per equity share, showing a listing day gain/loss of 16.95 (19.94%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Beta Drugs IPO stock moved from its listing price of ₹ 101.95 to the current price of ₹1884.45 per equity share, reflecting a change of 1,748.41% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Beta Drugs IPO issue date of May 30, 2025 and CMP of ₹1884.45, the estimated CAGR is approximately 50.03%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
₹ 101.95
Previous Day Closing
₹ 1876.50
Beta Drugs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Beta Drugs Financial Review Page
Merchant Banker(s) of Beta Drugs IPO: Pantomath Capital Advisors Private Limited
Beta Drugs IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Beta Drugs IPO listed at a listing price of 101.95 against the offer price of 85.00.
The current market price of Beta Drugs is 1884.45.
Why Us?
